Michael Ehlers
Chief Executive Officer at Limelight Bio, Inc.
Profile
Founder of Intergalactic Therapeutics, Inc. and Replicate Bioscience, Inc., Michael D.
Ehlers is a businessperson who has been at the helm of 5 different companies and currently is Chairman, President & Chief Executive Officer of Ascidian Therapeutics, Inc., Executive Chairman & Secretary at Aulos Bioscience, Inc., Board Chairman at Replicate Bioscience, Inc., Chairman of Intergalactic Therapeutics, Inc. and Chief Executive Officer of Limelight Bio, Inc. He is also on the board of The McKnight Endowment Fund for Neuroscience, Nine Square Therapeutics, Inc., Initial Therapeutics Inc and Nereid Therapeutics, Inc. and Chief Scientific Officer & Venture Partner at Apple Tree venture Managemnet Llc.
In the past Michael D.
Ehlers held the position of Senior Vice President, Head-BioTherapeutics R&D at Pfizer Inc., Executive VP-Research & Development at Biogen, Inc. and Director-Neuroproteomics Laboratory at Duke University.
He received an undergraduate degree from California Institute of Technology and a graduate degree and a doctorate from The Johns Hopkins University School of Medicine.
Michael Ehlers active positions
Companies | Position | Start |
---|---|---|
The McKnight Endowment Fund for Neuroscience
The McKnight Endowment Fund for Neuroscience Investment Trusts/Mutual FundsMiscellaneous The McKnight Endowment Fund for Neuroscience operates as a philanthropic organization. Its services include grantmaking, coalition-building and encouragement of strategic policy reforms. The company was founded by William L. McKnight in 1989 and is headquartered in Minneapolis, MN. | Director/Board Member | - |
Limelight Bio, Inc.
Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Chief Executive Officer | 2019-09-30 |
Ascidian Therapeutics, Inc.
Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Chief Executive Officer | 2023-11-07 |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Director/Board Member | - |
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Founder | - |
Aulos Bioscience, Inc.
Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Chairman | - |
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Private Equity Investor | 2019-09-30 |
Initial Therapeutics Inc
Initial Therapeutics Inc BiotechnologyHealth Technology Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | Director/Board Member | - |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Founder | 2020-02-29 |
░░░░ ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Michael Ehlers
Companies | Position | End |
---|---|---|
░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Michael Ehlers
California Institute of Technology | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
BIOGEN INC. | Health Technology |
Private companies | 10 |
---|---|
Apple Tree venture Managemnet Llc//vc
Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Finance |
The McKnight Endowment Fund for Neuroscience
The McKnight Endowment Fund for Neuroscience Investment Trusts/Mutual FundsMiscellaneous The McKnight Endowment Fund for Neuroscience operates as a philanthropic organization. Its services include grantmaking, coalition-building and encouragement of strategic policy reforms. The company was founded by William L. McKnight in 1989 and is headquartered in Minneapolis, MN. | Miscellaneous |
Limelight Bio, Inc.
Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
Nine Square Therapeutics, Inc.
Nine Square Therapeutics, Inc. BiotechnologyHealth Technology Nine Square Therapeutics, Inc. provides biotechnology services. The company was founded in 2020 and is headquartered in New York, NY. | Health Technology |
Initial Therapeutics Inc
Initial Therapeutics Inc BiotechnologyHealth Technology Opal Biosciences, Inc. operates as a biotechnology company. The company is headquartered in New York, NY. | Health Technology |
Ascidian Therapeutics, Inc.
Ascidian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascidian Therapeutics, Inc. operates as a biotechnology research and development company. The company is headquartered in Brighton, MA. | Health Technology |
Nereid Therapeutics, Inc.
Nereid Therapeutics, Inc. BiotechnologyHealth Technology Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA. | Health Technology |
Aulos Bioscience, Inc.
Aulos Bioscience, Inc. BiotechnologyHealth Technology Aulos Bioscience, Inc. operates as a biotechnology firm. The company is headquartered in Cambridge, MA. | Health Technology |
Replicate Bioscience, Inc.
Replicate Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Replicate Bioscience, Inc. is a clinical-stage biopharmaceutical company based in San Diego, CA. The company focuses on creating novel oncology treatments to prevent drug resistance using its synrgy technology. Replicate aims to enhance the effectiveness of many immuno-oncology regimens in early stages of care and is developing its own pipeline of immuno-oncology products in breast, lung, and prostate cancers. Replicate is differentiated by a team of srrna experts, a customizable library of synthetic srrna vectors, and end-to-end development capabilities. The company harnesses the body's natural protein-making power and uses synthetic biology to design unique self-replicating rnas (srrnas) that can direct that power to fight disease. The company was founded by Nathaniel Whang, Zachary Hartman, Michael D. Ehlers, Herbert Kim Lyerly, Andrew J. Geall, and Nathaniel Whang has been the CEO since incorporation. | Commercial Services |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Intergalactic Therapeutics, Inc. is a gene therapy company based in Baltimore, MD. The company is revolutionizing gene therapies with a novel non-viral platform comprised of its versatile synthetic and episomal c3dna molecules. The company uses a customized approach to focal therapeutic delivery using its lead delivery technology, the comet pulsed electric field system, and a proprietary cell-free manufacturing process invented to make gene therapy safer and more accessible for patients. With programs in ophthalmology, oncology, respiratory diseases, and expansion areas including CNS, renal, and musculoskeletal, Intergalactic Therapeutics is dedicated to transforming genetic medicine. The company was founded by Michael D. Ehlers, and Theresa G. H. Heah has been the CEO of the company since 2023. | Health Technology |